Shares of Henry Schein HSIC were unchanged after the company reported Q4 results.
Quarterly Results
Earnings per share were up 3.09% year over year to $1.00, which beat the estimate of $0.99.
Revenue of $3,165,700,000 higher by 18.61% from the same period last year, which beat the estimate of $2,880,000,000.
Outlook
Henry Schein said it sees FY21 adjusted EPS at or above $3.51.
Details Of The Call
Date: Feb 17, 2021
Time: 10:00 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/7zheip24
Price Action
Company's 52-week high was at $74.89
Company's 52-week low was at $41.85
Price action over last quarter: Up 16.83%
Company Description
Henry Schein is the largest wholesaler of dental and medical products to office-based practitioners. The company has been established for approximately 90 years and operates across nearly 30 distribution centers to offer hundreds of thousands of products to customers globally. Henry Schein also offers practice management products that include software products, technical, financial, and educational services. The company recently spun off its animal health business.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.